Analystreport

Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors